Rybelsus is a once-daily semaglutide tablet that the FDA approved for adults with type 2 diabetes, to improve blood sugar control alongside diet and exercise and to lower the risk of major cardiovascular events in people at high risk. It works like the natural gut hormone GLP-1. It is not approved for weight loss; the weight-management version of oral semaglutide is the Wegovy pill. This guide covers how Rybelsus works, the label’s dosing steps, side effects and what is worth tracking (Rybelsus prescribing information, section 1).
US update: Novo Nordisk is replacing Rybelsus with Ozempic tablets, the same daily semaglutide in a newer formulation, which the FDA approved under the Ozempic name in February 2026 (Novo Nordisk). Rybelsus shipments to US wholesalers stopped in May 2026. Ozempic tablets start at 1.5 mg, then 4 mg, with 9 mg if more blood sugar control is needed; Rybelsus 7 mg corresponds to 4 mg and 14 mg to 9 mg, and switching needs a new prescription (Illinois Medicaid provider notice; label, section 2.3). Brand names and strengths differ by country, so check with your pharmacist.
What Rybelsus is and how it works
Rybelsus (semaglutide) is a GLP-1 receptor agonist taken by mouth. GLP-1 is a hormone released after eating. Medicines in this class mimic it, which supports insulin release when blood sugar is high, lowers glucagon, slows stomach emptying and affects appetite signals in the brain. Because semaglutide is a peptide that stomach acid and enzymes would normally break down, the tablet has strict rules about how to take it (see below).
Semaglutide is also the ingredient in the injections Ozempic (type 2 diabetes) and Wegovy (weight management). If you are comparing them, see Ozempic vs Wegovy: key differences and weight loss pills vs GLP-1 injections. The oral weight-management option is covered in the Wegovy pill guide.
Weight change can happen on Rybelsus, but it is not the label’s purpose. If weight management is your goal, that is a conversation for your prescriber about which medicine is appropriate for you.
Rybelsus dosing and how to take it
The label starts low and steps up. Your prescriber may adjust the plan.
| Days | Daily dose | Notes |
|---|---|---|
| 1 to 30 | 3 mg | Starting dose; the label says it is not effective for blood sugar control |
| 31 to 60 | 7 mg | First dose meant for glycemic control |
| 61 onward | 7 mg, or 14 mg if more glycemic control is needed | Maintenance |
Source: Rybelsus prescribing information, section 2.2. The same label also covers Ozempic tablets, a separate product with its own strengths; the two are not interchangeable mg for mg.
How the label says to take it (section 2.1):
- Take one tablet once daily, on an empty stomach, in the morning, with up to 4 ounces of plain water. No other liquids.
- Swallow it whole. Do not split, crush or chew it.
- Wait at least 30 minutes after the tablet before eating, drinking or taking other oral medicines.
- If you miss a dose, skip it and take the next dose the following day.
Always follow your own prescription and pharmacist’s instructions, and ask your prescriber before changing anything.
Side effects
The most common adverse reactions in the label’s placebo-controlled trials (at least 5% of people) were nausea, abdominal pain, diarrhea, decreased appetite, vomiting and constipation. For example, nausea was reported by 20% of people on 14 mg, 11% on 7 mg and 6% on placebo. Overall, gastrointestinal reactions occurred in 41% of people on 14 mg, 32% on 7 mg and 21% on placebo, and most nausea, vomiting and diarrhea happened during dose escalation (Rybelsus label, section 6.1, PDF).
The label also carries a boxed warning about thyroid C-cell tumors seen in rodents, and warns about pancreatitis, gallbladder disease, low blood sugar when combined with insulin or sulfonylureas, kidney injury from dehydration, diabetic retinopathy complications, severe allergic reactions and aspiration during anesthesia. It is contraindicated with a personal or family history of medullary thyroid carcinoma or MEN 2.
Seek urgent care for severe or lasting stomach pain (sometimes spreading to the back), repeated vomiting, a lump in the neck, trouble swallowing or persistent hoarseness, or signs of an allergic reaction. Talk to your prescriber about any side effect that bothers you or does not go away. For more on managing common symptoms, see GLP-1 side effects: what to expect and how to manage them.
What to track on Rybelsus
Because the tablet depends on timing, a simple log helps you spot patterns and gives your prescriber something concrete:
- Dose strength and the time you took it, and whether you waited the 30 minutes
- Missed doses
- Side effects, with when they started and how long they lasted
- Meals and protein, and water, especially if you have stomach upset
- Weight, measured the same way each week
- Blood sugar readings, if your doctor asked you to take them
Mingo is a GLP-1 tracker for iPhone and Android that lets you log doses, food and protein, side effects and weight in one place. It doesn’t replace your doctor. Get the app.
Key takeaways
- Rybelsus is a daily semaglutide tablet approved for type 2 diabetes, not for weight loss.
- The label starts at 3 mg for 30 days, then 7 mg, with 14 mg only if more blood sugar control is needed.
- Take it first thing, with plain water, on an empty stomach, and wait 30 minutes before food, drink or other pills.
- Gastrointestinal side effects are the most common and mostly occur while the dose is stepped up. Report severe or persistent symptoms.
- A log of doses, symptoms and weight makes follow-up visits more useful.
Frequently asked questions
What is Rybelsus used for?
Rybelsus is approved for adults with type 2 diabetes to improve blood sugar control along with diet and exercise, and to reduce the risk of major cardiovascular events in adults at high risk. It is not approved for weight loss.
How does Rybelsus work in the body?
It mimics the hormone GLP-1. This supports insulin release when blood sugar is high, lowers glucagon, slows stomach emptying and influences appetite. The effect on blood sugar builds over the dose steps rather than appearing on day one.
How do I take Rybelsus correctly?
Once daily, on an empty stomach in the morning, swallowed whole with up to 4 ounces of plain water, then wait at least 30 minutes before eating, drinking or taking other medicines. If you miss a dose, skip it and take the next one the following day.
What are common Rybelsus side effects?
Nausea, abdominal pain, diarrhea, decreased appetite, vomiting and constipation. They are most common while the dose is being increased. Serious but less common problems include pancreatitis and gallbladder disease, so contact your prescriber about severe or lasting symptoms.
Is Rybelsus safe for long-term use?
Rybelsus is intended as ongoing treatment for type 2 diabetes, and the label includes a cardiovascular outcomes trial that followed people for a median of about four years. Whether it is right for you over the long term, and what monitoring you need, is something to review regularly with your prescriber.
